Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Zhiqi Pharmaceutical Technology is a specialized contract research and manufacturing organization (CRO/CDMO) based in Shanghai, China. Founded in 2016 and headquartered in the Zhangjiang Hi-Tech Park, the company provides high-end chemical synthesis and R&D services to the global pharmaceutical and biotechnology industries. Their core technical expertise focuses on the development of complex molecules, specifically PROTAC linkers, ADC payloads and linkers, and nucleoside analogues. The company offers a comprehensive suite of services including custom synthesis, process optimization, and scale-up manufacturing from milligram to kilogram scales. Shanghai Zhiqi maintains an extensive catalog of over 10,000 specialized building blocks and intermediates designed to accelerate drug discovery timelines. By leveraging advanced synthetic technologies, the company supports clients across various therapeutic areas, with a particular emphasis on oncology and antiviral research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Zhiqi.